日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and evaluation of patient education material for splenectomy patients

脾切除患者患者教育材料的开发与评估

Kita, Masahiko; Morita, Ryo; Shirano, Michinori

An Improved Dengue Virus Serotype-Specific Non-Structural Protein 1 Capture Immunochromatography Method with Reduced Sample Volume

一种改进的登革病毒血清型特异性非结构蛋白1捕获免疫层析法,所需样品量更少

Sretapunya, Warisara; Buranachat, Thitiya; Prasomthong, Montita; Tantikorn, Rittichai; Sa-Ngarsang, Areerat; Naemkhunthot, Sirirat; Meephaendee, Laddawan; Wongjaroen, Pattara; Tanaka, Chika; Shimadzu, Yoriko; Ogata, Katsuya; Kaihatsu, Kunihiro; Morita, Ryo; Shirano, Michinori; Phadungsombat, Juthamas; Sasaki, Tadahiro; Kubota-Koketsu, Ritsuko; Samune, Yoshihiro; Nakayama, Emi E; Shioda, Tatsuo

Efficacy and safety of immune checkpoint inhibitors in advanced non-small cell lung cancer with idiopathic interstitial pneumonia or interstitial lung abnormalities: NJLCG2301

免疫检查点抑制剂治疗伴有特发性间质性肺炎或间质性肺异常的晚期非小细胞肺癌的疗效和安全性:NJLCG2301

Okumura, Fumihiko; Tanaka, Hisashi; Onodera, Katsuhiro; Morita, Ryo; Inomata, Minehiko; Suzuki, Aya; Sugisaka, Jun; Minemura, Hiroyuki; Jingu, Daisuke; Kudo, Satoshi; Kikuchi, Hajime; Yoshimura, Naruo; Tsushima, Fumiyasu; Kakeda, Shingo; Tasaka, Sadatomo

Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902

一项针对既往未接受治疗的转移性非小细胞肺癌患者的联合放疗和帕博利珠单抗加化疗的 II 期试验:NJLCG 1902

Tsukita, Yoko; Umezawa, Rei; Nakagawa, Taku; Anbai, Akira; Makiguchi, Tomonori; Tanaka, Hisashi; Horii, Yosuke; Suzuki, Aya; Morita, Ryo; Nogawa, Hitomi; Yokouchi, Hiroshi; Kimura, Nozomu; Jingu, Keiichi; Inoue, Akira; Sugiura, Hisatoshi; Miyauchi, Eisaku

Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression in elderly patients: a subgroup analysis of HOT/NJLCG2001

帕博利珠单抗一线治疗PD-L1高表达老年非小细胞肺癌患者的真实世界数据:HOT/NJLCG2001亚组分析

Tateishi, Kazunari; Mizugaki, Hidenori; Ikezawa, Yasuyuki; Morita, Ryo; Yokoo, Keiki; Sumi, Toshiyuki; Aso, Mari; Kikuchi, Hajime; Nakamura, Atsushi; Sekikawa, Motoki; Yoshiike, Fumiaki; Kitamura, Yasuo; Kimura, Nozomu; Hachiya, Tsutomu; Tsurumi, Kyoji; Agatsuma, Toshihiko; Megumi, Furuta; Nakamura, Keiichi; Jingu, Daisuke; Yamamoto, Hiroshi; Kosaka, Makoto; Yokouchi, Hiroshi

Patient-specific vascular models for optimal catheter selection: Two aneurysm embolization cases

基于患者个体血管模型的优化导管选择:两例动脉瘤栓塞病例

Morita, Ryo; Abo, Daisuke; Fujii, Takaaki; Kinota, Naoya; Kato, Daisuke; Yamasaki, Kouji; Kanaya, Motoma; Harada, Taisuke; Sugita, Osamu; Kawamura, Norio; Taketomi, Akinobu; Kudo, Kohsuke

Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer

老年晚期非小细胞肺癌患者的免疫疗法或化疗免疫疗法

Tsukita, Yoko; Tozuka, Takehiro; Kushiro, Kohei; Hosokawa, Shinobu; Sumi, Toshiyuki; Uematsu, Mao; Honjo, Osamu; Yamaguchi, Ou; Asao, Tetsuhiko; Sugisaka, Jun; Saito, Go; Shiihara, Jun; Morita, Ryo; Katakura, Seigo; Yasuda, Takehiro; Hisakane, Kakeru; Miyauchi, Eisaku; Morita, Satoshi; Kobayashi, Kunihiko; Asahina, Hajime

Impact of Cachexia and First-Line Systemic Therapy for Previously Untreated Advanced Non-Small Cell Lung Cancer: NEJ050A

恶病质和一线全身治疗对既往未接受治疗的晚期非小细胞肺癌的影响:NEJ050A

Miura, Keita; Shukuya, Takehito; Furuya, Naoki; Morita, Ryo; Kisohara, Akira; Mouri, Atsuto; Watanabe, Satoshi; Tanaka, Hisashi; Hirata, Aya; Hakozaki, Taiki; Hamai, Kosuke; Matsumoto, Naoko; Watanabe, Kana; Ashinuma, Hironori; Miyauchi, Eisaku; Sugano, Koji; Hosokawa, Shinobu; Amano, Koji; Morita, Satoshi; Kobayashi, Kunihiko; Maemonodo, Makoto; Takahashi, Kazuhisa

Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101)

EGFR 突变型非小细胞肺癌患者接受放化疗后使用度伐利尤单抗治疗:一项真实世界研究 (HOT2101)

Tsuji, Kosuke; Mizugaki, Hidenori; Yokoo, Keiki; Kobayashi, Maki; Kawashima, Yosuke; Kimura, Nozomu; Yokouchi, Hiroshi; Kikuchi, Hajime; Sumi, Toshiyuki; Kawai, Yasutaka; Kobashi, Kenta; Morita, Ryo; Ito, Kenichiro; Kitamura, Yasuo; Minemura, Hiroyuki; Nakamura, Keiichi; Aso, Mari; Honjo, Osamu; Tanaka, Hisashi; Takashina, Taichi; Tsurumi, Kyoji; Sugisaka, Jun; Tsukita, Yoko; Konno, Satoshi; Oizumi, Satoshi

Real-world first-line treatment with pembrolizumab for non-small cell lung carcinoma with high PD-L1 expression: Updated analysis

帕博利珠单抗一线治疗PD-L1高表达非小细胞肺癌的真实世界疗效:最新分析

Ikezawa, Yasuyuki; Morita, Ryo; Mizugaki, Hidenori; Tateishi, Kazunari; Yokoo, Keiki; Sumi, Toshiyuki; Kikuchi, Hajime; Kitamura, Yasuo; Nakamura, Atsushi; Kobayashi, Maki; Aso, Mari; Kimura, Nozomu; Yoshiike, Fumiaki; Megumi, Furuta; Tanaka, Hisashi; Sekikawa, Motoki; Hachiya, Tsutomu; Nakamura, Keiichi; Hommura, Fumihiro; Sukoh, Noriaki; Ito, Kenichiro; Kikuchi, Takashi; Agatsuma, Toshihiko; Yokouchi, Hiroshi